NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

The company didn't release TLD. As I stated they are following NEJM media embargo policy which doesn't allow the company to publish TLD, since the journal must have exclusivity on publication, but they can share it with regulators, investigators who are not company employees can present it at scientific meetings, and finally patient advocacy groups can publish it on their websites. This allows the data to get out there among experts in the field though the general public isn't made aware of it until the media embargo gets lifted. At that point the company can send out their TLR PR which will hit the Bloomberg Terminal.